QDENGA, India's first dengue vaccine, receives approval for use, marking a significant milestone in dengue prevention efforts.
The approval comes at a critical time for public health, as reported dengue cases in India have increased 11-fold in the past ...
Qdenga, cleared this week for ages 4 to 60, is one of only a few dengue vaccines in the world. It is to be injected in two ...
New Delhi, Jul 21 (PTI) The government on Tuesday said Takeda Biopharmaceuticals India’s dengue vaccine, QDENGA, has been granted market authorisation after a comprehensive scientific evaluation of ...
The health ministry said the approval was supported by evidence generated through an extensive global clinical development ...
India approves its first dengue vaccine, Qdenga, as CDSCO grants marketing authorisation to Takeda's vaccine, marking a major ...
India has approved its first vaccine for the prevention of dengue, with the Central Drugs Standard Control Organisation (CDSCO) granting marketing authorisation to Japanese drugmaker Takeda for its ...
India has approved its first vaccine for the prevention of dengue, with the Central Drugs Standard Control Organisation ...
Takeda Biopharmaceuticals India Pvt Ltd. today announced that the Drug Controller General of India (DCGI) has granted market ...
India has approved its first dengue vaccine as cases of the mosquito-borne disease surge in South Asia. Japan's Takeda ...
Japan's Takeda Pharmaceutical's dengue vaccine QDENGA has been approved by India's drug regulator, making it the first dengue vaccine to be approved in the country, the company's unit said on Monday ...
The San Joaquin County Mosquito and Vector Control District will not increase its benefit assessment rates for the 2026-27 fiscal year. The district's Board of Trustees ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results